Search

Author/Creator Stein, Mark N

1. Effect of alvimopan on gastrointestinal recovery and length of hospital stay after retroperitoneal lymph node dissection for testicular cancer. (March 2019)

Authors:
Radadia, Kushan D; Farber, Nicholas J; Tabakin, Alexandra L; Wang, Wei; Patel, Hiren V; Polotti, Charles F; Weiss, Robert E; Elsamra, Sammy E; Kim, Isaac Y; Singer, Eric A; Stein, Mark N; Mayer, Tina M; Jang, Thomas L
Journal:
Journal of clinical urology
Issue:
Volume 12:Number 2(2019)
Page Start:
122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial. Issue 6 (June 2021)

Authors:
Yu, Evan Y; Petrylak, Daniel P; O'Donnell, Peter H; Lee, Jae-Lyun; van der Heijden, Michiel S; Loriot, Yohann; Stein, Mark N; Necchi, Andrea; Kojima, Takahiro; Harrison, Michael R; Hoon Park, Se; Quinn, David I; Heath, Elisabeth I; Rosenberg, Jonathan E; Steinberg, Joyce; Liang, Shang-Ying; Trowb...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 6(2021)
Page Start:
872
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I-II study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): the KEYNOTE-046 trial. (4th November 2015)

Authors:
Haas, Naomi B; Stein, Mark N; Tutrone, Ronald; Perini, Rodolfo; Denker, Andrew; Mauro, David; Fong, Lawrence
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗